STAAR Surgical reported revenue of $18.9 million for the fourth quarter, a 15% increase from the corresponding quarter in 2012, according to a press release.
GAAP net loss was $876,000, or $0.02 per diluted share, for the fourth quarter, compared with a net loss of $1.4 million, or $0.04 per diluted share, for the fourth quarter 2012.
Global sales of the Visian ICL increased 31% during the fourth quarter and 26% for the full year.
For full year 2013, net sales increased to $72.2 million, up from $63.8 million in 2012, a growth of 13%. Foreign currency changes unfavorably affected net sales by $3.8 million in 2013 compared with $62,000 in 2012.
Full year 2013 net GAAP income was $397,711, or $0.01 per diluted share, compared with a loss of $1.8 million, or $0.05 per diluted share, reported in 2012.
Total revenue for the full year 2013 grew by 13% over 2012.